These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 1262785)

  • 21. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes.
    Seligmann BE; Fletcher MP; Gallin JI
    J Immunol; 1983 Apr; 130(4):1902-9. PubMed ID: 6131922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further studies on the structural requirements for synthetic peptide chemoattractants.
    Freer RJ; Day AR; Radding JA; Schiffmann E; Aswanikumar S; Showell HJ; Becker EL
    Biochemistry; 1980 May; 19(11):2404-10. PubMed ID: 7387981
    [No Abstract]   [Full Text] [Related]  

  • 23. Characteristics of N-formyl-methionyl-leucyl-phenylalanine as an inducer of lysosomal enzyme release from human neutrophils.
    Smith RJ; Wierenga W; Iden SS
    Inflammation; 1980 Mar; 4(1):73-88. PubMed ID: 7390615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH; Kay AB
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
    Fletcher MP; Seligmann BE; Gallin JI
    J Immunol; 1982 Feb; 128(2):941-8. PubMed ID: 6274963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-Formylmethionyl-leucyl-phenylalanine: Different releasing effects on human neutrophils and rat mast cells.
    Fantozzi R; Brunelleschi S; Soldaini GB; Blandina P; Masini E; Raimondi L; Mannaioni PF
    Agents Actions; 1983 Apr; 13(2-3):218-21. PubMed ID: 6191552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines.
    Pike MC; Fischer DG; Koren HS; Snyderman R
    J Exp Med; 1980 Jul; 152(1):31-40. PubMed ID: 7400755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli.
    Marasco WA; Phan SH; Krutzsch H; Showell HJ; Feltner DE; Nairn R; Becker EL; Ward PA
    J Biol Chem; 1984 May; 259(9):5430-9. PubMed ID: 6371005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A highly active chemotactic peptide analog incorporating the unusual residue 1-aminocyclohexanecarboxylic acid at position 2.
    Sukumar M; Raj PA; Balaram P; Becker EL
    Biochem Biophys Res Commun; 1985 Apr; 128(1):339-44. PubMed ID: 3985973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor.
    Dalpiaz A; Ferretti ME; Vertuani G; Traniello S; Scatturin A; Spisani S
    Eur J Pharmacol; 2002 Feb; 436(3):187-96. PubMed ID: 11858798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU; Wissler JH; Damerau B
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH.
    Selvatici R; Falzarano S; Franceschetti L; Mollica A; Guerrini R; Siniscalchi A; Spisani S
    FEBS J; 2008 Feb; 275(3):449-57. PubMed ID: 18167144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
    Ward PA; Sulavik MC; Johnson KJ
    Am J Pathol; 1984 Aug; 116(2):223-33. PubMed ID: 6087668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L; Aksamit RR
    J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.
    Pagani Zecchini G; Nalli M; Mollica A; Lucente G; Paglialunga Paradisi M; Spisani S
    J Pept Res; 2002 Jun; 59(6):283-91. PubMed ID: 12010519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some remarkable effects of thiopeptide and derived linkages on lysozyme release from neutrophils by esters of the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (f-Met-Leu-Phe-OR).
    Belleau B; Lajoie G; Sauve G; Rao VS; di Paola A
    Int J Immunopharmacol; 1989; 11(5):467-71. PubMed ID: 2807625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.